Browse > Article

Development of the Dissolution Test for Viquidil Hydrochloride Capsules and Alibendol Tablets  

Hwang, Joung-Boon (Gyeongin Regional Food and Drug Administration, Hazardous Substances Analysis Division)
Koo, Eun-Joo (Gyeongin Regional Food and Drug Administration, Hazardous Substances Analysis Division)
Go, Seu-Youn (Gyeongin Regional Food and Drug Administration, Hazardous Substances Analysis Division)
Cho, Kyung-Chul (Gyeongin Regional Food and Drug Administration, Hazardous Substances Analysis Division)
Moon, Hyun-Ju (Gyeongin Regional Food and Drug Administration, Hazardous Substances Analysis Division)
Cho, Soo-Yeul (Gyeongin Regional Food and Drug Administration, Hazardous Substances Analysis Division)
Kang, Chan-Soon (Gyeongin Regional Food and Drug Administration, Hazardous Substances Analysis Division)
Shon, Yeo-Won (Gyeongin Regional Food and Drug Administration, Hazardous Substances Analysis Division)
Kim, Young-Ok (National Institute of Food and Drug Safety Evaluation, Scientific Drug Evaluation and Research Division)
Sohn, Kyung-Hee (National Institute of Food and Drug Safety Evaluation, Scientific Drug Evaluation and Research Division)
Cho, Dae-Hyun (Gyeongin Regional Food and Drug Administration, Hazardous Substances Analysis Division)
Publication Information
YAKHAK HOEJI / v.54, no.5, 2010 , pp. 348-353 More about this Journal
Abstract
The dissolution test method and an analytical procedure by HPLC were developed and validated for viquidil hydrochloride capsules and alibendol tablets. These drugs were not yet characterized by the dissolution specifications in Korean Pharmaceutical Codex. So, with each reference and test drugs, we did the preliminary and standard experiments based on the Korean Pharmacopeia Guideline of dissolution testing for solid oral dosage forms. The dissolution test for viquidil hydrochloride capsules was carried out under sink conditions as follows: dissolution medium water, paddle rotation speed 50 rpm and vessel volume 900 ml. More than 90% of its label amount was released within 30 min in this method. Also the dissolution test for alibendol tablets was carried out under sink conditions as follows: dissolution medium water, paddle rotation speed 100 rpm and vessel volume 900 ml. More than 90% of its label amount was released within 45 min in this method. The dissolution samples were analyzed with a precise and accurate HPLC method. The developed dissolution test showed specificity, linearity, precision and accuracy within the acceptable range. The dissolution testing method described above was adequate for the purpose and may be proposed as a pharmacopeial standard to assess the performance of viquidil hydrochloride capsules and alibendol tablets.
Keywords
dissolution test; viquidil hydrochloride capsules; alibendol tablets;
Citations & Related Records
연도 인용수 순위
  • Reference
1 식품의약품안전청 통계연보 (2005).
2 Gudrun, F. : Drug Inform. J. 35, 865 (2001).
3 Food and Drug Administration : Guidance for Industry. Dissolution Testing of Immediate Release Solid Oral Dosage Forms. US department of health and human services/Food and drug administration/Center for drug evaluation and research, Rockville MD (1997).
4 식품의약품안전청 : 의약품등 분석법의 밸리데이션에 대한 지침. 대한약전 제 9 개정.
5 식품의약품안전청 : 경구용의약품의 용출 규격 설정 지침. 대한약전 제 9 개정.
6 식품의약품안전청 용역연구개발사업 : 의약품의 제제동등성평가(III)-경구용 제제의 제제동등성 평가 사홍기 (2004).
7 FDA, Center for Drug Evaluation and Research, Guidance for Industry-Extended release oral dosage forms : development, evaluation and application of in vitro/in vivo correlation. September (1997).
8 식품의약품안전청 용역연구개발사업 : 비교용출시험과 용출규격의 상관성 연구. 사홍기 (2004).
9 식품의약품안전청 용역연구개발사업 : 의약품의 제제동등성평가(II)-경구용 제제의 제제동등성 평가. 사홍기 (2003).
10 식품의약품안전청 연구개발사업 : 의약품 규격의 국제화사업(I). 박상애 등 (2003).
11 Ansel, H., Allen Jr. L. and Popovich, N. : Pharmaceutical Dosage Forms and Drug Delivery systems (7th ed.), Lippincott Williams & Wilkins, Baltimore (1999).